c Intra-abdominal polymicrobial infections cause significant morbidity and mortality. An experimental mouse model of Candida albicans-Staphylococcus aureus intra-abdominal infection (IAI) results in 100% mortality by 48 to 72 h postinoculation, while monomicrobial infections are avirulent. Mortality is associated with robust local and systemic inflammation without a requirement for C. albicans morphogenesis. However, the contribution of virulence factors coregulated during the yeast-tohypha transition is unknown. This also raised the question of whether other Candida species that are unable to form hyphae are as virulent as C. albicans during polymicrobial IAI. Therefore, the purpose of this study was to evaluate the ability of non-albicans Candida (NAC) species with various morphologies and C. albicans transcription factor mutants (efg1/efg1 and cph1/cph1) to induce synergistic mortality and the accompanying inflammation. Results showed that S. aureus coinoculated with C. krusei or C. tropicalis was highly lethal, similar to C. albicans, while S. aureus-C. dubliniensis, S. aureus-C. parapsilosis, and S. aureus-C. glabrata coinoculations resulted in little to no mortality. Local and systemic interleukin-6 (IL-6) and prostaglandin E 2 (PGE 2 ) levels were significantly elevated during symptomatic and/or lethal coinfections, and hypothermia strongly correlated with mortality. Coinoculation with C. albicans strains deficient in the transcription factor Efg1 but not Cph1 reversed the lethal outcome. These results support previous findings and demonstrate that select Candida species, without reference to any morphological requirement, induce synergistic mortality, with IL-6 and PGE 2 acting as key inflammatory factors. Mechanistically, signaling pathways controlled by Efg1 are critical for the ability of C. albicans to induce mortality from an intra-abdominal polymicrobial infection. I ntra-abdominal infection (IAI) is a broad term used to describe numerous infections caused by the invasion of microorganisms into the abdominal cavity. These infections can range from appendicitis to complicated peritonitis and are initiated by microbes entering the abdominal cavity through a variety of routes, including bowel perforation, laparotomy, intestinal hernias, and insertion of medical devices such as peritoneal catheters (reviewed in reference 1). These infections often are polymicrobial in nature, which complicates diagnosis and treatment. Accordingly, infections with multiple microbes can result in amplified pathogenicity, also known as "infectious synergism" (2-4), which may accelerate disease progression or protect microbes from host responses (5), resulting in higher morbidity and mortality (6, 7).Polymicrobial IAIs involving fungi result in mortality rates between 50 and 75%, compared to 10 to 30% for polymicrobial bacterial infections (8-11). The majority of polymicrobial fungal IAIs are caused by Candida albicans (12, 13). However, IAIs caused by non-albicans Candida (NAC) species are becoming more common (14). C. al...